Covid-19 Impact on Global Intracranial Aneurysm Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Intracranial Aneurysm Treatment Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Intracranial Aneurysm Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Surgical Clipping
  • 1.4.3 Endovascular Coiling
  • 1.4.4 Flow Diverters
  • 1.4.5 Others
• 1.5 Covid-19 Implications on Market by Application
  • 1.5.1 Global Intracranial Aneurysm Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Intracranial Aneurysm Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Intracranial Aneurysm Treatment Industry
    • 1.6.1.1 Intracranial Aneurysm Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Intracranial Aneurysm Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Intracranial Aneurysm Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Covid-19 Implications on Global Intracranial Aneurysm Treatment Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Intracranial Aneurysm Treatment Growth Trends by Regions
  • 2.2.1 Intracranial Aneurysm Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Intracranial Aneurysm Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Intracranial Aneurysm Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Intracranial Aneurysm Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Intracranial Aneurysm Treatment Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Intracranial Aneurysm Treatment Players by Market Size
  • 3.1.1 Global Top Intracranial Aneurysm Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Intracranial Aneurysm Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Intracranial Aneurysm Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Intracranial Aneurysm Treatment Market Concentration Ratio
  • 3.2.1 Global Intracranial Aneurysm Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Intracranial Aneurysm Treatment Revenue in 2019
• 3.3 Intracranial Aneurysm Treatment Key Players Head office and Area Served
• 3.4 Key Players Intracranial Aneurysm Treatment Product Solution and Service
• 3.5 Date of Enter into Intracranial Aneurysm Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global Intracranial Aneurysm Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Intracranial Aneurysm Treatment Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Intracranial Aneurysm Treatment Market Size by Application (2015-2020)
• 5.2 Global Intracranial Aneurysm Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Intracranial Aneurysm Treatment Market Size (2015-2020)
• 6.2 Intracranial Aneurysm Treatment Key Players in North America (2019-2020)
• 6.3 North America Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 6.4 North America Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Intracranial Aneurysm Treatment Market Size (2015-2020)
• 7.2 Intracranial Aneurysm Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 7.4 Europe Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Intracranial Aneurysm Treatment Market Size (2015-2020)
• 8.2 Intracranial Aneurysm Treatment Key Players in China (2019-2020)
• 8.3 China Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 8.4 China Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Intracranial Aneurysm Treatment Market Size (2015-2020)
• 9.2 Intracranial Aneurysm Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 9.4 Japan Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Intracranial Aneurysm Treatment Market Size (2015-2020)
• 10.2 Intracranial Aneurysm Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Intracranial Aneurysm Treatment Market Size (2015-2020)
• 11.2 Intracranial Aneurysm Treatment Key Players in India (2019-2020)
• 11.3 India Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 11.4 India Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Intracranial Aneurysm Treatment Market Size (2015-2020)
• 12.2 Intracranial Aneurysm Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Intracranial Aneurysm Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Intracranial Aneurysm Treatment Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Medtronic
  • 13.1.1 Medtronic Company Details
  • 13.1.2 Medtronic Business Overview and Its Total Revenue
  • 13.1.3 Medtronic Intracranial Aneurysm Treatment Introduction
  • 13.1.4 Medtronic Revenue in Intracranial Aneurysm Treatment Business (2015-2020))
  • 13.1.5 Medtronic Recent Development
• 13.2 Microport Scientific Corporation
  • 13.2.1 Microport Scientific Corporation Company Details
  • 13.2.2 Microport Scientific Corporation Business Overview and Its Total Revenue
  • 13.2.3 Microport Scientific Corporation Intracranial Aneurysm Treatment Introduction
  • 13.2.4 Microport Scientific Corporation Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.2.5 Microport Scientific Corporation Recent Development
• 13.3 B. Braun
  • 13.3.1 B. Braun Company Details
  • 13.3.2 B. Braun Business Overview and Its Total Revenue
  • 13.3.3 B. Braun Intracranial Aneurysm Treatment Introduction
  • 13.3.4 B. Braun Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.3.5 B. Braun Recent Development
• 13.4 Stryker
  • 13.4.1 Stryker Company Details
  • 13.4.2 Stryker Business Overview and Its Total Revenue
  • 13.4.3 Stryker Intracranial Aneurysm Treatment Introduction
  • 13.4.4 Stryker Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.4.5 Stryker Recent Development
• 13.5 Johnson and Johnson
  • 13.5.1 Johnson and Johnson Company Details
  • 13.5.2 Johnson and Johnson Business Overview and Its Total Revenue
  • 13.5.3 Johnson and Johnson Intracranial Aneurysm Treatment Introduction
  • 13.5.4 Johnson and Johnson Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.5.5 Johnson and Johnson Recent Development
• 13.6 Microvention Inc.
  • 13.6.1 Microvention Inc. Company Details
  • 13.6.2 Microvention Inc. Business Overview and Its Total Revenue
  • 13.6.3 Microvention Inc. Intracranial Aneurysm Treatment Introduction
  • 13.6.4 Microvention Inc. Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.6.5 Microvention Inc. Recent Development
• 13.7 Codman Neuro (Integra Lifesciences)
  • 13.7.1 Codman Neuro (Integra Lifesciences) Company Details
  • 13.7.2 Codman Neuro (Integra Lifesciences) Business Overview and Its Total Revenue
  • 13.7.3 Codman Neuro (Integra Lifesciences) Intracranial Aneurysm Treatment Introduction
  • 13.7.4 Codman Neuro (Integra Lifesciences) Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.7.5 Codman Neuro (Integra Lifesciences) Recent Development
• 13.8 Raumedic AG
  • 13.8.1 Raumedic AG Company Details
  • 13.8.2 Raumedic AG Business Overview and Its Total Revenue
  • 13.8.3 Raumedic AG Intracranial Aneurysm Treatment Introduction
  • 13.8.4 Raumedic AG Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.8.5 Raumedic AG Recent Development
• 13.9 Integra Life Sciences Corporation
  • 13.9.1 Integra Life Sciences Corporation Company Details
  • 13.9.2 Integra Life Sciences Corporation Business Overview and Its Total Revenue
  • 13.9.3 Integra Life Sciences Corporation Intracranial Aneurysm Treatment Introduction
  • 13.9.4 Integra Life Sciences Corporation Revenue in Intracranial Aneurysm Treatment Business (2015-2020)
  • 13.9.5 Integra Life Sciences Corporation Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer